📊 Midday Market Take
| S&P 500 | ▼ | -0.37% |
| Nasdaq | ▼ | -1.30% |
| Dow Jones | ▲ | +0.31% |
Happy Monday. Markets are open and already showing some weakness — the S&P 500 is down 0.37%, the Nasdaq is taking the bigger hit at -1.30%, and the Dow is bucking the trend with a modest +0.31% gain. Tech is leading the selloff while blue chips are holding their ground, which tells you a lot about where the nerves are right now.
Keep your eyes on the technology sector as the session plays out. That Nasdaq slide is worth taking seriously as a signal, not just noise. If you are looking to position, rotating toward defensive names or dividend-paying industrials could give you some cushion while growth stocks find their footing.
Definium Therapeutics, Inc.
|
Price
$37.80
|
Today
+54.43%
|
30 Day
+71.45%
|
90 Day
+117.90%
|
1 Year
+468.92%
|
Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder. The company was formerly known as Mind Medicine (MindMed) Inc.
3 Reasons to Watch DFTX
- Phase 3 Depression Trial Just Hit Its Mark. Definium's DT120 orally disintegrating tablet posted positive topline results from its Phase 3 Emerge study in major depressive disorder, a milestone that sent shares surging 54% in a single session. A successful Phase 3 readout for a single-dose depression treatment is the kind of binary event that can permanently reprice a clinical-stage biotech.
- The Chart Is Doing Something Unusual. DFTX is up 117% over the past 90 days and nearly 470% over the past year, and Monday's 54% pop didn't come out of nowhere — it's the latest leg of a sustained move, not a random spike. When a stock runs this hard across multiple timeframes, it tells you institutional money has been building a position, not just day traders chasing headlines.
- An LSD-Based Drug for Depression Is a Legitimacy Moment. The fact that a psychedelic-derived compound just cleared a Phase 3 bar for major depressive disorder is a watershed event for the entire brain health category, not just this company. Watch for follow-on attention around DT402, the company's Phase 2a autism candidate, as investors will be stress-testing how deep this pipeline actually runs.
He revived EVs, revolutionized space, and built the biggest satellite network. But this AI tech could go down in history as the crown jewel of Elon's career. Nvidia CEO Jensen Huang says, "What Elon and his team has achieved is singular. It's never been done before."
Get the full story here.Top Market Headlines
Best Income Stocks to Buy for June 22nd
YZCAY, WTTR and FMX made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 22nd, 2026.
Read The Full Story$44 Trillion "Super Convergence": Elon's Biggest Move EVER? (Ad)
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall of Fame Trader Jon Najarian now says EVERYONE is missing an even bigger story about the SpaceX IPO… That it's just the start of an Elon Musk $44 trillion "Superconvergence…" An event that could kick off as soon as October 28th.
Click here now to watch hall of fame trader Jon Najarian's full prediction.
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the AlertsNew Strong Buy Stocks for June 22nd
FMX, SVM, ORN, CVNA and WTTR have been added to the Zacks Rank #1 (Strong Buy) List on June 22nd, 2026.
Read The Full StoryAre Finance Stocks Lagging Prologis (PLD) This Year?
Here is how Prologis (PLD) and Atlanticus Holdings Corporation (ATLC) have performed compared to their sector so far this year.
Read The Full StoryTrump Admin to Pump $1 Billion into this "Off-the-Radar" AI Stock (Ad)
The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into MP Materials. The stock popped 200%. It bought 10% of Trilogy Metals. The stock popped 500%. And now, Trump has chosen this AI stock for a $1 billion payday.
Click here for the full story and stock pick (free).3 Monster Dividend Stocks to Hold for the Next 10 Years
Clorox's Purell acquisition strengthens long-term growth while supporting a nearly 5% dividend yield.
Read The Full StoryThe Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert (Ad)
Luke Lango was ranked America's #1 stock picker in 2020. He was mentored by two hedge fund billionaires from the Soros network and trained at Caltech. His readers have had the chance to see gains as high as AMD +8,500%... Nvidia +5,000%... Tesla +3,500%... Palantir +1,000%... and Apple +890%.
Now he's releasing his next big pick.
For years, we've been told SpaceX is a rocket company. But according to new satellite images from 300 miles above the Earth's surface, there is something very strange going on at SpaceX right now that has nothing to do with space. It could soon replace our need for foreign oil forever and ignite a $10 trillion boom for the stocks involved.
Click here to learn more.